Form 8-K - Current report:
SEC Accession No. 0001104659-21-116352
Filing Date
2021-09-16
Accepted
2021-09-16 16:01:59
Documents
12
Period of Report
2021-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2127757d1_8k.htm   iXBRL 8-K 28461
  Complete submission text file 0001104659-21-116352.txt   202621

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA regn-20210914.xsd EX-101.SCH 3191
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20210914_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20210914_pre.xml EX-101.PRE 22714
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2127757d1_8k_htm.xml XML 3523
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 211257946
SIC: 2834 Pharmaceutical Preparations